Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A simple mucus test for cancer screening

A M Shamsuddin1

  • 1Department of Pathology, University of Maryland, School of Medicine, Baltimore, USA.

Anticancer Research
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6).

Anticancer research·2001
Same author

Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans.

BioFactors (Oxford, England)·2001
Same author

Usefulness of galactose oxidase-Schiff test in rectal mucus for screening of colorectal malignancy.

Anticancer research·2001
Same author

Mammary tumor inhibition by IP6: a review.

Anticancer research·2000
Same author

Antiplatelet activity of inositol hexaphosphate (IP6).

Anticancer research·2000
Same author

Metabolism and cellular functions of IP6: a review.

Anticancer research·2000

A new rectal mucus test detects galactose-N acetylgalactosamine (Gal-GalNAC), an early marker for colon cancer. This accurate, cost-effective screening method aids early detection and may reduce unnecessary colonoscopies.

Area of Science:

  • Oncology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Colon cancer pathogenesis involves early molecular changes, leading to the 'field effect' theory.
  • Identifying early carcinogenesis markers is crucial for effective cancer screening strategies.

Purpose of the Study:

  • To develop and evaluate a novel rectal mucus test for early colon cancer detection.
  • To assess the clinical utility and cost-effectiveness of the Gal-GalNAC marker test.

Main Methods:

  • Development of a rectal mucus test utilizing enzymatic oxidation to detect galactose-N acetylgalactosamine (Gal-GalNAC).
  • Evaluation of test performance including sensitivity, specificity, and predictive values.
  • Comparison with existing screening methods like fecal occult blood tests.

Related Experiment Videos

Main Results:

  • The Gal-GalNAC marker is expressed in rectal mucus of patients with colon cancer or precancerous lesions.
  • The test demonstrates high sensitivity, specificity, positive, and negative predictive values.
  • The screening method is cost-effective and shows high accuracy, potentially reducing unnecessary colonoscopies.

Conclusions:

  • The developed rectal mucus test for Gal-GalNAC is a valuable tool for early colon cancer detection and screening.
  • This accurate and cost-effective test can improve colon cancer control strategies and reduce healthcare costs.
  • The Gal-GalNAC marker's presence in other cancers suggests its potential as a general cancer screening biomarker.